ask="1.25"
ask_size="5000"
average_daily_volume="13875"
bid="N/A"
bid_size="N/A"
book_value="0.00"
change="+0.00"
change_from_200_day_moving_average="-0.03"
change_from_50_day_moving_average="0.01"
change_from_52_week_high="-0.51"
change_From_52_week_low="0.11"
change_in_percent="+0.00%"
close="1.10"
dividend_pay_date="10/7/2013"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="1.92"
ebitda="0.00"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="N/A"
ex_dividend_date="10/8/2013"
float_shares="N/A"
high="1.10"
high_52_weeks="1.61"
last_trade_date="3/7/2017"
last_trade_price="1.10"
last_trade_size="100"
last_trade_time="1:04pm"
low="1.08"
low_52_weeks="0.99"
market_capitalization="N/A"
moving_average_200_day="1.13"
moving_average_50_day="1.09"
name="Celgene Corporation"
notes="N/A"
one_year_target_price="N/A"
open="1.05"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-2.50%"
percent_change_from_50_day_moving_average="+1.10%"
percent_change_from_52_week_high="-31.68%"
percent_change_from_52_week_low="+11.11%"
previous_close="1.10"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="N/A"
short_ratio="0.00"
stock_exchange="NGM"
symbol="CELGZ"
volume="226"
weeks_range_52="0.99 - 1.61"
